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Monitoring Brain Activity with 
Protein Voltage and Calcium 
Sensors
Douglas A. Storace1, 3, Oliver R. Braubach2, 3, Lei Jin1, Lawrence B. Cohen1, 2, 3 & Uhna Sung2
Understanding the roles of different cell types in the behaviors generated by neural circuits requires 
protein indicators that report neural activity with high spatio-temporal resolution. Genetically 
encoded fluorescent protein (FP) voltage sensors, which optically report the electrical activity 
in distinct cell populations, are, in principle, ideal candidates. Here we demonstrate that the FP 
voltage sensor ArcLight reports odor-evoked electrical activity in the in vivo mammalian olfactory 
bulb in single trials using both wide-field and 2-photon imaging. ArcLight resolved fast odorant-
responses in individual glomeruli, and distributed odorant responses across a population of glomeruli. 
Comparisons between ArcLight and the protein calcium sensors GCaMP3 and GCaMP6f revealed that 
ArcLight had faster temporal kinetics that more clearly distinguished activity elicited by individual 
odorant inspirations. In contrast, the signals from both GCaMPs were a saturating integral of 
activity that returned relatively slowly to the baseline. ArcLight enables optical electrophysiology of 
mammalian neuronal population activity in vivo.
Introduction
Traditional optical imaging techniques using intrinsic signals1,2 or organic dyes for measuring voltage3 
and calcium4,5, are limited in their ability to distinguish the cell types contributing to the signal, except in 
special cases6,7. In contrast, protein reporters of neural activity can be targeted to genetically distinct cell 
types. ArcLight is a protein voltage sensor that can detect single action potentials in cultured mammalian 
neurons8, and in vivo in Caenorhabditis elegans9 and Drosophila10. These results make ArcLight a strong 
candidate for in vivo functional imaging in mammalian preparations.
However, measurements made in one type of preparation have not necessarily translated to good 
performance in another. Early protein voltage sensors11 resulted in poor expression in mammalian cells12, 
and other sensors that worked well in mammalian cells in vitro13,14 suffered from poor in vivo perfor-
mance15–17.
A voltage sensor with a good signal-to-noise ratio could facilitate understanding the function of 
the mammalian olfactory bulb. Olfactory sensory neuron axons converge in regions of neuropil called 
glomeruli, forming connections with the apical dendrites of mitral and tufted cells, whose axons project 
out of the bulb. The transformation accomplished by the olfactory bulb is currently unclear. The net-
works of bulb interneurons surrounding each glomerulus18, the inter-glomerular processing via mitral 
and tufted cell lateral dendrites, and the feedback projections from cortical areas19 must all contribute 
to this transformation.
Calcium signals have often been used as a surrogate for measuring action potential activity for glo-
merular measurements7,20. However, calcium concentration changes are slower than voltage signals, 
aren’t always present in response to voltage changes, and calcium signals in mitral cells are elicited by 
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subthreshold activity and thus calcium signals do not provide unambiguous information about mitral cell 
action potential activity21. Furthermore, calcium signals will be slowed by the binding kinetics of calcium 
with the sensor and the slowing will depend on expression levels22. A fast voltage sensor would provide 
a more direct measurement, as recent studies demonstrated that behaviorally relevant information is 
obtained very rapidly in rodents, in a single sniff23,24.
The present study used ArcLight to record the population signals that largely came from mitral and 
tufted cell dendritic tufts in each glomerulus. The ArcLight voltage signals were compared with those 
from the protein calcium sensors GCaMP325 and GCaMP6f 26 using paired recordings from opposite 
olfactory bulb hemispheres. ArcLight odor-evoked responses could be detected in the glomerular layer 
in single trials using wide-field and 2-photon imaging, and simultaneous wide-field measurements from 
opposite bulbs with ArcLight and GCaMP3 or GCaMP6f revealed that ArcLight’s temporal kinetics were 
substantially faster than both GCaMPs.
Results
Injecting AAV vectors; expression patterns. The mouse olfactory bulb responds to different odor-
ants with distinct spatial and temporal patterns of glomerular activation7,27,28. We tested whether ArcLight 
can be used as an in vivo reporter of the glomerular output via mitral/tufted cells, and compared it to 
the calcium sensors GCaMP3 and GCaMP6f. Adeno-associated virus (AAV1) vectors carrying genes for 
ArcLight and GCaMP3 or GCaMP6f (Fig. 1a-b) were injected into separate bulb hemispheres between 
10 and 50 days prior to optical measurements (Fig. 1c). Injections were targeted towards the rostral part 
of the bulb but expression tended to be widespread in the injected hemisphere.
Experiments in cultured neurons demonstrated that ArcLight traffics to the plasma membrane8. We 
developed an AAV1 ArcLight vector with the 2A peptide followed by mCherry with a nuclear localiza-
tion sequence (Fig. 1a) which facilitates identification of transduced neurons. Expression of the ArcLight 
and the calcium sensors were histologically examined based on the sensor fluorescence. When viewed 
at high magnification, ArcLight often appeared targeted to neuronal membranes (Fig. 1df, arrow in d), 
while GCaMP3 expressing neurons mainly had cytoplasmic fluorescence (Fig. 1g, arrow).
At lower magnification, ArcLight (Fig. 1h-j) and GCaMP3 (Fig. 1k) vectors appeared to target sim-
ilar populations of neurons in the external layers of the bulb. Both were largely selective for mitral and 
tufted neurons (Fig. 1, compare j, k), although an occasional juxtaglomerular neuron also appeared to 
be labeled. We presume that the labeled glomeruli are the result of dendritic expression in the primary 
dendritic tufts of the mitral/tufted neurons.
Imaging individual glomerular output with ArcLight using wide-field epifluorescence or 
2-photon microscopy. We first examined whether ArcLight can be used to measure in vivo 
odor-evoked responses from the glomerular tufts of mitral/tufted cells using epifluorescence and 2-photon 
scanning microscopy. Injections of the ArcLight AAV (Fig. 1a,c) generally resulted in relatively uniform 
fluorescence across the dorsal surface (Fig. 2a). Odorant presentation evoked glomerular-sized changes 
in ArcLight fluorescence (Fig. 2b) that were relatively large and fast (Fig. 2c-d,f). ArcLight signals rep-
resenting depolarizations are shown as upward signals8. The optical signals recorded using wide-field 
epifluorescence (at 125 Hz) were clearly coupled to respiration (Fig. 2c-d). The 2-photon measurements 
recorded at 8 Hz were not (Fig. 2f), although increasing the 2-photon sampling rate to 100 Hz by reduc-
ing the number of scan lines improved the signal-to-noise and resulted in signals that were coupled to 
respiration (Fig.  2g). Higher concentrations of saturated vapor generally resulted in larger amplitude 
optical signals (Fig. 2f).
Bath application of TTX to the dorsal surface of the bulb eliminated the response to odorants. TTX 
significantly reduced the power of the optical signals at the respiration frequency before (74% ± 4 percent 
decrease, 1-sample t-test: t(3) = −17.4, p < 0.001) and during the odorant presentation (87% ± 2.2 percent 
decrease, 1-sample t-test: t(3) = −39.2, p < 0.001; 4 preparations). The ArcLight respiration coupled sig-
nals during the odorant presentation, and the smaller respiration coupling before and after the odorant 
presentation are both consistent with electrode recordings from individual mitral/tufted neurons show-
ing that action potential frequency is highly modulated by respiratory activity both in the presence and 
absence of odor23,29,30.
The ArcLight recordings were consistent across trials (Fig.  2d), suggesting that phototoxicity and 
photobleaching were limited. The ArcLight recordings have a late slow intensity increase that we presume 
results from interference from an intrinsic optical signal, which has the same direction and a similar 
slow time course2,31. Paired recordings from ArcLight injected and uninjected hemispheres had compa-
rable slow changes when measured with the filter set used for the ArcLight fluorescence measurements 
(Fig.  3a). A relatively small autofluorescence signal in the opposite direction can be seen in the unin-
jected bulb (Fig. 3a). This signal is not obvious in the ArcLight hemisphere because the relatively dim 
intrinsic fluorescence is overshadowed by the much brighter ArcLight fluorescence. In addition, intrin-
sic reflectance signals measured using 705 nm light were comparable in both injected and uninjected 
bulbs (Fig. 3b,d), suggesting that pharmacological effects of ArcLight was minimal. Similar results were 
obtained with GCaMP3 (not shown).
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Comparisons of odorant-evoked voltage and calcium signals. Calcium signals are frequently 
used as a surrogate for action potential measurements in vivo. We compared GCaMP signals to those 
using ArcLight in measurements made simultaneously in opposite hemispheres. Odorants presented for 
0.3 s often coincided with a single inhalation, which resulted in ArcLight and GCaMP3 (Fig. 4a-b, red 
versus green trace) or ArcLight and GCaMP6f (Fig.  4c-d, red versus blue trace) fluorescence signals 
that were easily detectable in single trials. Increases in calcium from the GCaMPs are shown as upward 
signals.
The ArcLight and GCaMP signals had distinctly different amplitudes and time courses (Fig.  4a,c). 
ArcLight had a much smaller fractional fluorescence change (Δ F/F) than either GCaMP. Single inha-
lations of ethyl tiglate or isoamyl acetate (10% of saturated vapor) evoked ArcLight, GCaMP3 and 
GCaMP6f signal sizes (Δ F/F) of 1.2% ± 0.05 (6 preparations, 69 glomeruli, range: 0.31-2.6%), 8.9% ± 0.5 
(5 preparations, 84 glomeruli, range: 1.3-18.5%) and 24.8% ± 1.3 (4 preparations, 65 glomeruli, range: 7.1-
48.1%) respectively. However, ArcLight had a faster onset, rise time, and decay. Quantitative comparisons 
of the time course of ArcLight (red), GCaMP3 (green) and GCaMP6f (blue) responses to single odorant 
inhalations were made from glomerular sized peaks of activation across the bulb (Fig. 4e-h). ArcLight 
signals reach 50% of their maximum more quickly (Fig. 4e,h, F(2, 215) = 112.1, p < 0.0001), have a shorter 
rise time (Fig.  4f,h, F(2, 215) = 78.23, p < 0.0001), and return to 50% of the baseline faster (Fig.  4g,h, 
F(2, 214) = 76.26, p < 0.0001) than GCaMP3 and CGaMP6f signals (one-way ANOVAs were used for all 
Figure 1. Schematic of constructs, virus injections, and results of histological examination of the 
fluorescence of ArcLight and GCaMP3 in injected olfactory bulb hemispheres. (a-b) Constructs for (a) 
ArcLight and (b) GCaMP3/6f AAV1 vectors. The mCherry in the ArcLight construct includes a nuclear 
localization sequence to facilitate identification of transduced neurons. (c) Each AAV vector was injected 
into an olfactory bulb hemisphere at least 10 days prior to imaging. (d) High magnification confocal 
photomicrographs of ArcLight demonstrate membrane localization (arrow). (d) ArcLight, (e) mCherry and 
(f) merge. (g) High magnification photomicrograph of GCaMP3 fluorescence. The GCaMP3 fluorescence 
seems to fill the cytoplasm (arrow). (h-k) Low magnification confocal photomicrographs demonstrate 
expression patterns of the ArcLight (h-j) and GCaMP3 AAV vectors (k). Both vectors appeared to be 
selective for mitral/tufted cells in the outer layers of the bulb. Scale bars in g and k apply to d-g and h-k, 
respectively. onl, olfactory nerve layer; gl, glomerular layer; epl, external plexiform layer; mcl, mitral cell 
layer.
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comparisons, Tukey post-hoc comparisons confirmed that ArcLight was fastest, followed by GCaMP6f 
and GCaMP3). Samples for ArcLight, GCaMP3 and GCaMP6f in e-h include 69 (6 preparations), 84 (5 
preparations) and 65 (4 preparations) glomeruli, respectively.
Figure 2. Odor-evoked ArcLight signals in single trials using wide-field and 2-photon microscopy. (a-d) 
Wide-field epifluorescence microscopy. (a) Wide-field resting fluorescence intensity. (b) Glomerular patterns 
of activation after odor presentation. (c) Odor-evoked optical measurement from the region of interest 
marked with a red circle in a-b. The frame subtraction map in b is from an average of 3 respiration aligned 
trials with no spatial filtering. The optical measurement in c is from an unfiltered single trial (the respiration 
trace is filtered at 4 Hz). (d) Six unfiltered single trials aligned to the first sniff of odorant. The respiration 
trace is from one of the single trials. (e-g) 2-photon scanning microscopy. (e) 2-photon resting fluorescence 
intensity from the glomerular layer in the rostral bulb. (f) Optical measurements from glomerulus 1 in panel 
e in response to ethyl tiglate at 3 odor concentrations and an air alone presentation. The optical traces in 
f are averages of 2-3 respiration aligned trials (thick lines); single trials are shown as thin lines for the 3% 
saturated vapor condition. Measurements were recorded at a sampling frequency of 8 Hz, and the traces 
were Gaussian low-pass filtered at 2 Hz. (g) Increasing the 2-photon sampling rate improved the signal-
to-noise ratio and revealed respiration coupled ArcLight signals. The optical signal in panel g is from the 
smaller imaging area in panel e (512 × 16 pixels, thin red box in glomerulus 1) and is from an average of 3 
respiration aligned trials. The optical traces in g were recorded at a sampling frequency of 100 Hz, and were 
Gaussian low-pass filtered at 4 Hz. The respiration traces in panels f and g are from single trials. The data in 
a-c, d, and e-g are from three different preparations.
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We increased the length of the stimulus presentation from 0.3 s, to 0.6, 1, and 2 s, which increased 
the number of odorant inhalations (Fig.  5a-d). Regardless of the odorant duration, ArcLight record-
ings from the caudal-lateral region of the bulb were strongly coupled to respiration, where each inhala-
tion of the odorant was immediately followed by a peak in the ArcLight signal, and a nearly complete 
return toward the baseline during subsequent exhalations (Fig. 5a-d,2c,3a, red traces). Inhalation coupled 
responses were detectable with GCaMP3 (Fig.  5a-c, green traces) and GCaMP6f (Fig.  5d, blue trace), 
but these were much less prominent. All three sensors had power at the respiration frequency prior to 
odorant presentation, and all three sensors had a significant increase in power at the respiration fre-
quency during the odor presentation (repeated measures ANOVA F(1, 268) = 236.7, p < 0.0001) (Fig. 5e, 
compare light vs dark bars). However, a comparison of the three sensors normalized to the peak signal 
amplitude revealed that ArcLight has significantly more power at the respiration frequency than both 
GCaMPs before (one-way ANOVA F(2, 268) = 846.3, p < 0.0001) and during odorant presentation (F(2, 
268) = 190.2, p < 0.0001) (Tukey post hoc comparisons confirmed ArcLight was largest) (Fig. 5e). Samples 
for ArcLight, GCaMP3 and GCaMP6f include 73 (6 preparations), 117 (6 preparations) and 81 (5 prepa-
rations) glomeruli, respectively.
ArcLight always reached its peak response within a single inhalation of odorant (Fig. 5a-d, red traces). 
In contrast, GCaMP3 was slower and tended to take up to 3 sniffs to reach its peak response for a given 
odorant concentration (Fig.  5a-c, green traces). GCaMP6f was more responsive than GCaMP3, and 
reached 80% (± 0.07) of its peak after the first sniff (Fig.  5d, blue trace) at all tested odor concentra-
tions (not shown). When normalized to their peak signal amplitude, GCaMP6f signals were significantly 
larger than those of GCaMP3 for the first two sniffs (paired t-tests, Sniff1: t(7) = −8, p < 0.001, Sniff2: 
t(7) = −7.75, p < 0.001, Sniff3: t(7) = 0.39, p = 0.70).
Although ArcLight reports neuronal population activity faster than GCaMP3 and GCaMP6f, all 
three sensors had a large spread of temporal responses across a population of glomeruli (Fig.  4e-g). 
We examined whether temporal responsiveness was related to the dorsal position on the bulb. Both the 
voltage and the calcium measurements from rostral-medial glomeruli had slower onsets and a slower 
return to baseline than those located in the caudal-lateral bulb (Fig.  6a-b, dashed vs solid traces). The 
Figure 3. Time course of signals from ArcLight and uninjected hemispheres reveal that ArcLight signals 
are only present in the injected hemisphere, and the presence of ArcLight does not adversely affect 
intrinsic signals. (a) Measurements from injected (red trace) and uninjected hemispheres (black trace) using 
485 nm excitation light and 530 long pass emission. The presumed slow intrinsic light scattering signal (slow 
upward) is present in both hemispheres, although the flavoprotein autofluorescence signal52 is only clearly 
seen in the uninjected hemisphere. The control trace is taken from an average of three respiration aligned 
trials. The odor and respiration traces are from a single trial. The traces are low-pass filtered at 4 Hz and 
inverted. (b) Comparison of intrinsic light reflectance signals measured using 705 nm light from the same 
locations in panel a. Traces are from an average of 4 respiration aligned trials, are low pass filtered at 2 Hz, 
and are shown in their original orientation. (c) Resting fluorescence intensity image of ArcLight injected 
(top) and uninjected (bottom) olfactory bulb hemispheres measured using 485 nm incident light. Overlaid 
kernels indicate the locations used for the traces shown in a and b. (d) Population statistics comparing 
glomerular responses measured with intrinsic light reflectance signals at 705 nm in ArcLight injected and 
uninjected hemispheres. The population comparison is non-significant (p > 0.05 using a 2-sample t-test). 
Data included in d are from averages of 2-6 trials.
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time to reach 50% of the peak (Fig.  6c), time for 50% decay (Fig.  6d), or the power at the breathing 
frequency (Fig. 6e) as a function of bulb position all demonstrated that these temporal properties shift 
in the caudal-lateral to rostral-medial direction. This functional topography was evident in all five tested 
preparations and are consistent with previous reports20,32. Figure 6f shows frame subtractions of signals 
evoked by a single inhalation illustrating the changing patterns of activation at the times indicated by 
the gray bars in Fig. 6a. ArcLight signals in faster responding glomeruli in the caudal-lateral region were 
briefer (Fig. 6f1-f4), while the signals in slower glomeruli in the rostral-medial bulb were longer lasting 
(Fig. 6f2-f5). GCaMP3 signals were slower in onset and offset.
Comparison of ArcLight and GCaMP sensor response speed. The differences in time course and 
respiration coupling that we found between ArcLight and the GCaMPs are likely due to a combination 
of differences in the time course of the cellular voltage and calcium changes as well as the response 
speeds of the sensors. To further understand these differences, we compared the temporal kinetics of 
the ArcLight response to changes in membrane potential to published stopped flow data on GCaMP3 
and GCaMP6f responses to changes in calcium in solution26,33,34 (D. Kim, L. Looger, S Wang, personal 
communication).
ArcLight had onset and offset time constants of 20 and 30 msec, respectively for 80 mV depolarizing 
steps in HEK293 cells (Fig.  7a). GCaMP3 has onset time constants of 1100 and 250 msec for calcium 
steps to 250 nM and 490 nM (Fig. 7b, green line, time constants of 1100 and 250 msec are equivalent to 
cut-off frequencies of 0.14 Hz and 0.7 Hz)33. GCaMP6f is about 50% faster for calcium concentration 
steps to ~ 510 nM and ~ 940 nM (Fig. 7b, blue line) (D. Kim, L. Looger, S Wang, personal communica-
tion). Fig.  7c-e compares the temporal responses for ArcLight (c), GCaMP3 (d) and GCaMP6f (e) for 
Figure 4. ArcLight and GCaMP responses to a single inhalation of odorant. (a, c) Simultaneous 
measurements made of ArcLight and GCaMP3 (a) and ArcLight and GCaMP6f (c) injected hemispheres. 
Traces are from single trials low-pass filtered at 4 Hz. (b, d) Resting fluorescence intensity for the 
preparations in a and c with recording locations indicated by colored circles. (e-h) Quantitative comparison 
of temporal properties of ArcLight, GCaMP3 and GCaMP6f signals from all identified glomerular sized 
peaks of activation. The first negative peak of the respiration signal following the onset of the odorant was 
identified for each trial, and was defined as the start time (red circle in a). Selected time points for analysis 
are indicated as circles on the traces in a. (e-g) Histograms showing time to reach 50% of the peak (e), the 
rise time (f 10% to 90%), and the time for the peak to decay to 50% (g) for ArcLight (red), GCaMP3 (green) 
and GCaMP6f (blue). (h) Bar graphs showing mean (± s.e.m.) for the quantifications in e-g. Asterisks 
indicate significance at p < 0.001. R, rostral, L, lateral.
www.nature.com/scientificreports/
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selected steps of voltage and calcium. The decay constants for GCaMP3 and GCaMP6f are reported to 
be ~150 msec34 and 71 msec (D. Kim, L. Looger, S Wang, personal communication), respectively, when 
starting at a high calcium concentration. The concentration dependence of the decay times has not been 
reported. ArcLight has faster kinetics than either GCaMP.
Thus, ArcLight’s better ability to detect individual inspiration responses may be in part due to its 
faster temporal kinetics. To simulate the effect that slower temporal kinetics would have on the ArcLight 
signal, we determined the time course of the ArcLight signal in response to two breaths when the signal 
is filtered with a simple RC low-pass filter with time constants of 159, 250 and 1100 msec (equivalent to 
the on time constants of GCaMP3 for calcium steps of 250 nM, 490 nM and 610 nM) (Fig. 7f). Filtering 
with a 1100 msec time constant resulted in a onset signal that is similar to the GCaMP3 response onset 
(Figs 5–6, green traces), with an increased response amplitude with the second breath. However, none 
of the filters resulted in a greatly prolonged recovery of the signal like that seen with the GCaMPs 
(Figs  4–6). Thus, the GCaMP onset response kinetics appears to have an impact on one, but not all, 
aspects of the calcium measurement.
Discussion
We report the in vivo response of the genetically encoded FP voltage sensor, ArcLight8, in the mamma-
lian brain. Injections of an AAV1 vector resulted in widespread labeling of mitral and tufted neurons. 
This ArcLight expression made it possible to record odorant-evoked optical signals in single trials in vivo 
using both conventional wide-field optics and 2-photon imaging. Wide-field imaging was used to directly 
compare ArcLight measurements with those of the genetically encoded calcium reporters GCaMP3 and 
Figure 5. ArcLight, but not GCaMP optical signals have sufficiently fast temporal dynamics to clearly 
distinguish the neural activity resulting from individual odorant inhalations. (a-c) Simultaneous 
measurements of ArcLight (red) and GCaMP3 (green) signals in response to odorant presented for 0.6 s, 
1 s and 2 s (from the same preparation and bulb location as Fig. 4a). (d) ArcLight (red) and GCaMP6f 
(blue) measurements in response to odorant presented for 0.6 s (from the same preparation and bulb 
position location as Fig. 4c). Longer odorant presentations resulted in breath coupled responses that were 
very obvious for ArcLight, but relatively small for both GCaMPs. Traces in a-d are from single trials low-
pass filtered at 4 Hz. An unfiltered trace is included in a. (e) All three sensors had significant increases in 
power at the respiratory frequency during the odorant presentation (compare light and dark bars). ArcLight 
responses have significantly higher power (a.u., arbitrary units) than either GCaMP). The analysis in the 
caudal-lateral bulb used 3 glomeruli from each preparation that were located caudal-laterally, and were also 
strongly breath coupled. Asterisks indicate significance at p < 0.001.
www.nature.com/scientificreports/
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Figure 6. Wide-field microscopy: spatial organization of glomerular temporal heterogeneity. (a) 
ArcLight (red) and GCaMP3 (green) fluorescence traces measured from caudal (solid line) and rostral 
(dashed line) locations in response to one (a) or two (b) inspirations of an odorant. Glomeruli in the caudal-
lateral bulb responded faster, and had responses that were more tightly coupled to respiration. The traces 
in a and b are single trials filtered at 4 Hz. (c, d, e) Resting fluorescence intensity images with an overlay of 
activated glomerular regions of interest (colored circles) color coded to represent the time to reach 50% of 
the peak signal (c), the time for the peak signal to decay 50% (d), or the power at the respiratory frequency 
(e). The four arrows in C indicate the location of the regions of interest selected for the traces in a and b. 
(f) Frame subtractions of ArcLight and GCaMP3 recordings (average of 4 trials) taken at the time points 
indicated by the vertical gray bars in a.
www.nature.com/scientificreports/
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GCaMP6f 25,26. ArcLight signals had substantially faster temporal dynamics that easily visualized respira-
tory coupled activity.
The ArcLight signal likely reflects the population average of all the cells and processes expressing the 
sensor in the glomerular region of interest. Electrode measurements from individual mitral and tufted 
cells reveal that they produce action potentials that are tightly linked to the respiration cycle, and each 
cell can be tuned to a different phase of the sniff23,30,35. Thus, our ArcLight measurements appear to reflect 
the respiration driven envelope of this spiking activity36.
The odorant evoked in vivo response time course of ArcLight and the GCaMPs are dependent on the 
kinetics of the voltage and calcium changes they are designed to detect, as well as intrinsic properties 
of the protein sensors which include sensor expression levels and kinetics22. ArcLight and the GCaMPs 
have onset and decay kinetics that delay their responses to voltage and calcium (Fig. 7a-b). The onset and 
decay kinetics of the GCaMP sensor responses to step changes in calcium result from the binding and 
unbinding rates of calcium. The mechanism by which ArcLight works is not known; it has been hypoth-
esized to result from a movement of the S4 trans-membrane segment of the voltage sensitive domain of 
the Ciona protein that is transmitted to the attached super ecliptic pHluorin (A227D) chromophore8.
Figure 7. Comparison of sensor kinetic properties. Experimentally measured ArcLight values for 
different depolarizing steps are compared with published and personally communicated values for 
GCaMP3 and GCaMP6f. GCaMP3 and GCaMP6f are considerably slower in response to calcium 
changes than ArcLight is to membrane potential changes. (a) ArcLight onset (red) and offset (pink) time 
constants in response to different depolarizing steps from −70 mV in HEK293 cells. (b) GCaMP3 (green 
line), and GCaMP6f (blue line) onset time constants in response to different calcium steps26,33,34 (D. Kim, 
L. Looger, S Wang, personal communication). The GCaMP3 onset kinetics (green line) are the result of 
steps from 0 nM33. The green outlined GCaMP3 data point at 940 nM, and both GCaMP6f data points 
are in response to steps from 100 nM (D. Kim, L. Looger, S Wang, personal communication). (c, d, e) 
Normalized impulse responses for ArcLight (c), GCaMP3 (d), and GCaMP6f (e) to physiologically relevant 
steps of voltage and calcium (the selected GCaMP3 steps are indicated by colored data points in b). The 
GCaMP offset rates in d and e are shown as dashed lines to indicate the possibility that it could be longer 
for decreases from lower calcium concentrations. (f) ArcLight signals in response to two breaths low-pass 
filtered using time constants equivalent to those of GCaMP3 and GCaMP6f for steps of calcium.
www.nature.com/scientificreports/
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ArcLight’s onset and offset kinetics are faster than those of GCaMP3 and GCaMP6f over the physio-
logical range of voltage and calcium concentrations (Fig. 7a-b)26,34(D. Kim, L. Looger, S Wang, personal 
communication). The onset kinetics of the GCaMPs also depend on the calcium concentration (Fig. 7b, 
d, e). While their offset rates aren’t reported as a function of the starting calcium concentration26,34, it is 
plausible that the slow onset rates at lower calcium concentrations could be due to a high affinity calcium 
binding site with a slow off rate. Thus the offset time constants starting at lower calcium concentrations 
could be much slower than those reported (70-150 msec) from measurements starting at a high calcium 
concentration. The in vivo course of the GCaMP signal will also be affected by the amount of protein 
expression because of buffering effects22.
We presume that all of these factors play a role in the difference in the respiration modulation seen 
between ArcLight and the GCaMPs, an idea supported by the result showing that GCaMP6f is some-
what faster than GCaMP3 both in vivo and in solution (Figs  4 and 7). While ArcLight’s signals were 
substantially faster than those of either GCaMP, they were also substantially smaller. Thus, ArcLight and 
GCaMPs are complementary tools whose use depends on whether the more precise temporal resolution 
and membrane potential sensitivity of ArcLight outweighs the benefit of improved signal-to-noise ratios 
and calcium sensitivity of the GCaMPs.
That said, faster sensors will be important in determining brain function. The importance of fast 
temporal processing in olfactory processing has been emphasized in many recent studies23,24,37. Protein 
voltage sensors may also be useful in distinguishing the different responses of individual cell types. In 
the case of olfactory receptor neurons, calcium measurements from their glomerular axon terminals 
primarily reflect the action potential activity of those cells7. However, the apical dendrites of mitral 
cells have calcium transients that reflect subthreshold membrane potential changes in addition to those 
caused by action potentials21. Thus, calcium measurements from mitral cell apical dendrites likely reflect 
a combination of subthreshold and action potential activity20,38. A distinction between these two kinds 
of activity could be measured using two different protein voltage sensors that are preferentially tuned to 
different depolarization ranges39.
Earlier protein voltage sensors had limited in vivo utility in the mammalian nervous system because 
of poor quantum efficiency, small signal size, slow temporal dynamics and / or poor expression11,16,17,40–42. 
As a result, other attempts to use protein voltage sensors in vivo needed extensive averaging and/or 
processing to reveal stimulus-evoked signals (10 trials16, 20 trials17, 100 trials43, 10 trials44, 400 trials45, 
6-30 trials46).
Microbial rhodopsin based sensors (Arch/Arch D95N) have promising in vitro performance using 
high intensity illumination41,47. However, in vitro action potential responses could not be detected using 
the same imaging apparatus that was used for ArcLight48, likely because Arch and Arch D95N have 
50-100 times lower quantum efficiency. Because of the requirement for high intensity illumination, those 
microbial rhodopsin sensors, and later variants47,49 may not be useful for in vivo imaging in the mam-
malian brain.
Recently published sensors (e.g. MacQ-mCitrine and ASAP1) are reported to have in vitro perfor-
mance comparable to ArcLight, and thus may be promising alternatives50,51. However, a comparison of 
in vivo performance is not yet possible as there are presently no reports of ASAP1 measurements in vivo, 
and those of MacQ-mCitrine were carried out in a different preparation.
The results from repeated imaging trials were relatively consistent (Fig. 2d), which suggested that sub-
stantial photo-bleaching or photodynamic effects were not present with ArcLight or the GCaMPs at the 
incident intensities we used. Our comparison of intrinsic activity from injected and control hemispheres 
did not detect a pharmacological effect of either probe on normal bulb function (Fig. 3a-b, d). However, 
continued attention to these possibilities is desirable. The ArcLight signals were sufficiently large and fast 
to be distinguished from the intrinsic light scattering and flavoprotein autofluorescence (Fig.  3a-b)1,52. 
The autofluorescence signal was very small in the presence of the increased fluorescence from ArcLight.
Our ArcLight and GCaMP AAV1 vectors used different promoters, the choice of which can alter the 
targeting to- and within neuronal populations. However, both CAG and the human synapsin 1 promoter 
are known to be highly specific for neurons53,54, and our histological examination (Fig.  1) suggested 
that both vectors had similar expression mainly targeted to mitral/tufted cells in the outer layers of the 
olfactory bulb. Therefore, we don’t believe the promoter choice had a substantial effect on the results 
presented here.
Anesthesia can have an effect on the response properties of individual mitral cells29,55, and that of 
the glomerular population signal20. That said, local field potential dynamics are mostly unaffected by the 
anesthetic used in our study, although they can cause a decrease in the overall power of the signal, and 
shift in gamma oscillations towards higher frequencies56. It is important for future studies to address the 
role of anesthetic on the glomerular voltage signal.
Our results show that ArcLight is useful for examining population neural activity in the in vivo mam-
malian nervous system, a result that is not predictable from measurements on in vitro or non-mammalian 
preparations. While we hope for the future development of improved voltage sensors (faster and larger 
signals, responses tuned to specific depolarization ranges, targeting to sub-cellular regions), ArcLight 
already has sufficient signal size and temporal dynamics to be useful for measuring electrical activity. 
In cells with a substantial post-synaptic calcium signal, a voltage sensor, can, in principle, be better 
than a calcium sensor at distinguishing action potentials from subthreshold events. A compelling reason 
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for using a protein voltage sensor over traditional organic voltage sensitive dyes is the ability to target 
them to specific cell types. The olfactory bulb has a strongly differentiated laminar structure amenable 
to genetic targeting20. While our AAV1 vector appeared to be selective for certain cell populations, this 
specificity is likely due to a combination of the AAV serotype and promoter. In the future we hope to 
develop cre-dependent AAV1 vectors that could be used to record from specific cell types, and extend 
the present 2-photon imaging results towards the goal of single cell optical electrophysiology in vivo in 
the mammalian brain.
Methods
AAV Vector. ArcLight A242-2A-nls-mCherry was constructed by fusing ArcLight A2428 with the self 
cleaving 2A peptide sequence followed by nuclear localized mCherry57. ArcLight A242-2A-nls-mCherry 
was inserted into the HindIII site of aavCAG Jx vector (Gene bank JN898959) in a forward orientation 
to create ArcLight A242-2A-nls-mCherry aavCAG Jx (Fig.  1a). This allowed constitutive expression of 
the voltage sensor under the CAG promoter in wild type (C57BL/6) mice. An adeno-associated virus 
serotype 1 (AAV1) of the ArcLight construct was produced at the Penn Vector Core at the University 
of Pennsylvania (www.med.upenn.edu), and has been made available for distribution. For experiments 
with GCaMP3 and GCaMP6f, we used AAV1s expressing the gene under the human synapsin 1 (Fig. 1b) 
promoter (#AV-1-PV1627 and AV-1-PV2822 purchased from the Penn Vector Core).
Surgery and imaging in adult mice. All experiments were performed in accordance with relevant 
guidelines and regulations. C57BL/6 mice (JAX, Bar Harbor, MA) were housed and handled, and all 
experiments were performed in accordance with a protocol approved by the Institutional Animal Care 
and Use Committees at Yale University and the Marine Biological Laboratory. For all surgical proce-
dures, female mice were anesthetized with a mixture of ketamine (90 mg kg−1) and xylazine (10 mg kg−1). 
Anesthesia was supplemented as needed to maintain areflexia, and anesthetic depth was monitored peri-
odically via the pedal reflex. Animal body temperature was maintained at approximately 37.5 C° using a 
heating pad placed underneath the animal. Local anesthetic (1% bupivacaine, McKesson Medical) was 
applied to all incisions. Respiration was recorded with a piezoelectric sensor.
For viral injections animals were anesthetized, and a small hole (< 1 mm) was made in the skull directly 
above the anterior part of one or both olfactory bulbs. AAV1 expressing either ArcLight, GCaMP3, or 
GCaMP6f was injected using a glass capillary (tip diameter 8–15 μm) approximately 500 μm below the 
surface of the bulb (Fig. 1c). Virus titres for ArcLight, GCaMP3 and GCaMP6f were 4.6e12 genome cop-
ies (GC) ml−1, 4.7e13 GC ml−1, and 4.3e13 GC ml−1, respectively. AAV injections ranged from 0.2 to 2 μl. 
The preparations in Fig. 1 received 2 μl injections of ArcLight and GCaMP3. The preparations in Fig. 2 
received 1.5 (a-c) and 2 μl (d,f-g) injection of ArcLight. The preparations in Fig. 4 received 1.5 μl injections 
of ArcLight and GCaMP3 and 1 μl injections of ArcLight and GCaMP6f. Injected mice received water 
supplemented with Carprofen (rimadyl) for a minimum of 3 days. We allowed a minimum of 10 days for 
sensor expression prior to optical measurements. Mice received either a single injection of ArcLight (16 
preparations) or GCaMP3 (1 preparation), injections of both ArcLight and GCaMP3 into separate hemi-
spheres (11 preparations), or both ArcLight and GCaMP6f into separate hemispheres (5 preparations). All 
of the wide-field fluorescence data are from dual injected preparations except for the results in Figs. 2–3. 
The results from single and dual injected preparations were consistent with each other.
For in vivo 2-photon imaging using ArcLight, mice were anesthetized and ~ 2 mm craniotomies were 
performed near the sites of the virus injection over the dorsal olfactory bulbs. The skull and dura were 
removed and replaced with agarose and a cover glass window. 2-photon imaging was performed with 
a modified MOM two-photon laser-scanning microscope (Sutter Instruments). Two-photon laser illu-
mination was provided by a mode-locked Ti-sapphire laser (Chameleon Vision, Coherent) and laser 
scanning was performed with a Cambridge Technology XY galvanometric scanning system (Cambridge 
Technologies). The tissue was illuminated with 920 nm laser light and scans were performed at var-
ying speeds ranging from frame rates of 3 Hz (512 × 512 pixels) to 100 Hz (512 × 16 pixels). 2-photon 
optical signals were collected with either a Nikon CFI APO LWD 25 × 1.10 N.A. or a Nikon CFI LWD 
16 × 0.80 N.A. water immersion objective (Nikon Instruments), passed through a 510 / 84 bandpass 
filter (Semrock) and converted to electrical signals with a GaAsP photomultiplier (Hamamatsu H10770).
For wide-field fluorescent imaging, mice were anesthetized, and the bone above both olfactory bulbs 
was either thinned or removed. The exposure was covered with agarose and sealed with a glass covers-
lip. The dorsal surface of both hemispheres was illuminated with 485 ± 25 nm light using epifluoresence 
illumination on a custom antediluvian Leitz Ortholux II microscope with either a tungsten halogen lamp 
or a 150 W Xenon arc lamp (Opti Quip) and a 515 nm long-pass dichroic mirror. Fluorescence emission 
above 530 nm was recorded with a sanguine NeuroCCD-SM256 camera with 2 × 2 binning at 125 Hz 
using NeuroPlex software (RedShirtImaging, Decatur, GA).
For intrinsic imaging, the dorsal surface was illuminated with 485 nm and 530 long-pass emission 
(autofluorescence; black trace) or 705 nm light (intrinsic reflectance) (Fig. 3a-b). Wide-field optical sig-
nals were measured using either a 4 × 0.16 NA (3.5 × 3.5 mm field of view), a 3.5x, 0.1 NA objective 
(4 × 4 mm field of view), or a 10x, 0.4 NA objective (1.4 × 1.4 mm field of view). All of the presented 
traces were collected using the 10x (Fig. 2d) or the 4x objective (all other traces); the data in Fig. 4e-h 
and Fig. 5e were collected with either the 4x or 3.5x objective.
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Bath application of TTX was performed in four preparations using a previously described protocol58. 
4−6 weeks after virus injection, the preparation was prepared as described above except that the dura was 
also removed. Following an imaging session lasting 1−2 hours, the coverslip and agarose was removed, 
and a piece of gelfoam (Henry Schein, Melville, NY) soaked with 30-50 μM TTX (Biotium, Hayward, 
CA) was placed on the brain surface. The gelfoam was left in place for 30 minutes, after which the brain 
was rinsed with saline and the agarose and coverslip were reapplied.
Odorant stimuli and delivery. Odorants (Sigma-Aldrich) were diluted from saturated vapor with 
cleaned air using a flow dilution olfactometer described previously59. The olfactometer was designed to 
provide a constant flow of air blown over the nares. Through a separate set of tubing, odorants were 
constantly injected into the olfactometer, but sucked away via a vacuum that was switched off during 
odorant presentation. Cross contamination was avoided by using separate Teflon tubing for each odorant. 
Odorants were delivered at different concentrations (between 0.5-10% of saturated vapor), although 10% 
of saturated vapor evoked the most consistent responses, and was used for all the wide-field imaging 
data presented in the paper. For wide-field imaging experiments odorants were also presented at different 
durations to examine the response to differing numbers of odorant inhalations. In most of these exper-
iments we tested 1-3 odorants including ethyl tiglate, isoamyl acetate, eugenol, and octanal. All of the 
traces shown in the figures were elicited by the presentation of ethyl tiglate. The data in the bar graphs 
in Fig. 4e-h,5e also include responses to isoamyl acetate.
Data Analysis. Odorant-evoked signals were collected in consecutive (3-6) odorant presentations sep-
arated by a minimum of 30 s. The individual trials were manually inspected, and occasional trials with 
obvious mechanical artifact were discarded. The onset of inhalation was defined as the first downward 
deflection following the first peak in the respiration recording after the start of the odorant presentation. 
Response latency values are given relative to the completion of the inhalation. Recordings were either 
examined as individual trials, or averaged after an alignment procedure where the time of the first inspira-
tion following the odorant presentation was identified and the individual recordings synchronized to this 
time. Aligned averaged traces were used in Figs 2b,f-g,3a-b,4e-h,5e and 6c-f. All other traces are the result 
of single trials. Unfiltered traces are shown in Figs  2c,d and 5a (thin red traces). All other traces were 
Gaussian low pass filtered at 4 or 6 Hz (Figs.  2f,3a,4a,c,5a-d and 6a-b) or at 2 Hz (Fig.  2f,3b). ArcLight 
signals representing depolarization are shown as upward signals8. For the GCaMPs, calcium increases 
are shown upward. Spatial maps of odorant evoked activation (Figs. 2b,6f) were made by subtracting the 
temporal average of the 1-2 s preceding the stimulus from a temporal average at the peak (Fig. 2b) or at 
different time points (Fig. 6f) during the response using frame subtraction in NeuroPlex. The frame sub-
traction map in Fig. 2b has no spatial filtering. The map in Fig. 6f was spatially smoothed using a low pass 
3 × 3 pixel kernel with the center pixel given a weight of 3, and a high pass 41 × 41 pixel Gaussian kernel. 
Glomeruli were visually identified as circular peaks of activation ~50–100 μm in diameter. The traces in 
all figures are the averaged signal from pixels in such glomerular sized regions of interest.
Odor-evoked intrinsic optical signals (reflectance) were measured at 705 nm as a test to determine 
whether the ArcLight and GCaMP3 viral injections had an effect on the odorant responses of the olfac-
tory bulb. Signals were examined in experiments that received an ArcLight or GCaMP3 injection into 
one hemisphere, with the other used as a control, although intrinsic signals from dual injected hemi-
spheres were also examined in 5 preparations; total glomeruli: NArcLight: 20, NGCaMP3: 25. Between 2-5 of 
the largest glomerular sized peaks of activation were identified using frame subtractions in NeuroPlex, 
and were used for the comparison of intrinsic signals in injected and uninjected hemispheres. Intrinsic 
signals recorded in injected and uninjected hemispheres in the same preparation were not different for 
single injections of ArcLight (Fig. 3d,4 preparations) or GCaMP3 (not shown, 1 preparation). Because 
we carried out only a single GCaMP3 alone measurement, we also compared the intrinsic signals from 
dual injections of ArcLight and GCaMP3. The intrinsic signals were similar in both hemispheres (not 
shown). These data suggested that neither ArcLight nor GCaMP3 injections had a substantial effect on 
olfactory bulb physiology.
In some experiments with large (> 1.5 μl) GCaMP virus injections a small signal originating from 
GCaMP3 or GCaMP6f could be detected in the hemisphere contralateral to the injection site. We found 
that lowering the virus injection volume helped to eliminate this cross-talk. Only preparations without 
cross-talk were used for the results reported here.
The response latency analysis in Fig.  4e-g was performed in identified glomeruli in trials in which 
the mouse took only a single sniff of odorant. A single GCaMP3 glomerulus was omitted for the decay 
analysis due to an exceptionally slow return to baseline. The breath coupling analysis in Fig.  5e was 
quantified by importing the respiration trace, and the ArcLight, GCaMP3 and GCaMP6f measurements 
into MATLAB (Fig.  5e). All traces were low pass filtered at 20 Hz and normalized to the maximum 
optical signal size (0-1). The peak power of the respiration trace was identified between 2-5 Hz for 
each preparation (ArcLight and GCaMP3 injected: 3.6 ± 0.1 Hz; 6 preparations; ArcLight and GCaMP6f 
injected: 3.1 ± 0.3 Hz; 5 preparations). A Fast Fourier transform (FFT) was computed on the traces (with 
a Hanning window) for the 2 s time period before, and during the odorant presentation. The power at 
that preparations respiration frequency (± 0.25 Hz) was measured for each trace. A repeated measures 
ANOVA was performed to compare differences in power between sensor type and stimulation time (i.e., 
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before or during odor presentation). After confirming a significant difference in stimulation and sensor, 
a one-way ANOVA was performed on the power measurements before and during odor presentation to 
examine significant differences between the three sensors (Fig. 5e, bottom). This analysis was also per-
formed on a subset of glomeruli taken from the most caudal-lateral bulb in each preparation (Fig. 5e, 
top, repeated measures ANOVA for stimulus: F(1, 48) = 264.5, p < 0.0001, one-way ANOVA before: F(2, 
48) = 155, p < 0.0001 and during odor (F(2, 48) = 117.2, p < 0.0001, Tukey tests confirmed ArcLight was 
largest).
Comparison of signal power at the respiration frequency before and after TTX application were 
performed by taking the optical signal from a single location on the bulb in each preparation. 1 and 
2-sample t-tests were performed to confirm that there were significant decreases in the optical power at 
the respiratory frequency following TTX application.
The GCaMP3 and GCaMP6f response to repeated inhalations was quantified by measuring the signal 
size (Δ F/F) of GCaMP3 and GCaMP6f at the peak response following each sniff, and normalizing the 
maximum response to 1. A single region of interest was selected for each preparation as being the most 
strongly breath coupled glomerular sized region of interest. Paired t-tests were used to compare the 
normalized GCaMP3 and GCaMP6f signals for the first 3 sniffs. The GCaMP3 and GCaMP6f responses 
were measured in 8 and 4 preparations, respectively.
Statistical analyses were performed in MATLAB, Origin 9 (OriginLab Corporation, Northampton, 
MA), SPSS (IBM Corporation, Armonk, NY) or Microsoft Excel.
Kinetic analysis of ArcLight and GCaMP signals. The onset and decay time constants for the bind-
ing of calcium to GCaMP3 and GCaMP6f for Fig.  7 were taken from published values and personal 
communication26,33,34 (D. Kim, L. Looger, S. Wang, personal communication). The effect of filtering the 



























ArcLight kinetics were experimentally measured in HEK293 cells (Fig. 7a,c). Recordings were made in a 
whole-cell configuration using a Patch Clamp PC-505B amplifier (Warner Instruments). Cells were held 
at −70 mV, and depolarized to either −30 mV, +10 mV or +50 mV. Optical traces were recorded using 
wide-field imaging on a Nikon Eclipse E6000FN upright microscope (Nikon Instruments) with a water 
immersion objective (60 x /1.00 NA), and the fluorescence changes were recorded with a NeuroCCD-SM 
camera (RedShirtImaging) at 1000 Hz. Probe dynamics were based on the fit to a single exponential 
equation. Double exponential fits were also calculated but the fit was only slightly improved8.





Histological Methods. After each imaging experiment, mice were given an overdose of euthasol, 
decapitated, and their brains were dissected and left in 4% paraformaldehyde for a minimum of 3 days. 
Each olfactory bulb was embedded in 3% agarose, and cut on a vibratome in 50–100 μm thick coronal 
sections. Mounted sections were coverslipped with VECTASHIELD Hard Set Mounting Medium with 
DAPI (Vector Labs, H-1500). Slides were examined using either a widefield epifluoresence microscope, 
or a Zeiss LSM-780 confocal microscope (Carl Zeiss Microsystems). The fluorescence filter sets for 
ArcLight/GCaMP3, mCherry and DAPI were 480/30 (center wavelength/band width; excitation), LP505 
(dichroic) and 535/40 (emission); 540/25, 565LP and 605/55; and 350/50, 400LP and 460/60, respectively. 
Images were analyzed and figures prepared using Zen Lite 2011 (Carl Zeiss Microsystems) and Adobe 
Photoshop and Illustrator (Adobe Systems Inc.).
ArcLight, GCaMP3, and GCaMP6f all exhibited strong fluorescence that was detectable without addi-
tional amplification steps. Their expression patterns were assessed relative to the cytoarchitecture identi-
fied using DAPI fluorescence. Expression patterns were generally consistent with the sections presented 
in Fig. 1d-k), although there was some variability in the spread of expression from the injection site and 
in the number of labeled neurons. There was never evidence of injections into one hemisphere labeling 
cell bodies in the superficial layers of the contralateral hemisphere. However, fluorescence was sometimes 
present in the deepest layers of the contralateral hemisphere (not shown).
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